InvestorsHub Logo
Followers 35
Posts 1771
Boards Moderated 0
Alias Born 09/25/2012

Re: None

Saturday, 06/06/2015 8:46:09 PM

Saturday, June 06, 2015 8:46:09 PM

Post# of 5006
I don't know if many of you are not paying attention or didn't notice but read this line on slide #29 from the Jefferies Presentation

" Extension study for Hypertrophic scars (Severe Cases)"

If RXI-109 wasn't working why would Rxi expand upon a new expansion study for more severe cases of hypertrophic scars? This leads me to believe the new added dosing is working even better. As the company would not target more severe cases of hypertrophic scars if the drug wasn't working in less severe cases of hypertrophic scars
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PHIO News